Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Yttrium_(90Y)_clivatuzumab_tetraxetan> ?p ?o. }
Showing items 1 to 34 of
34
with 100 items per page.
- Yttrium_(90Y)_clivatuzumab_tetraxetan abstract "Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody designed for the treatment of pancreatic cancer. The antibody itself, clivatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.The drug was developed by Immunomedics, Inc.".
- Yttrium_(90Y)_clivatuzumab_tetraxetan atcPrefix "none".
- Yttrium_(90Y)_clivatuzumab_tetraxetan casNumber "943976-23-6".
- Yttrium_(90Y)_clivatuzumab_tetraxetan wikiPageID "33058043".
- Yttrium_(90Y)_clivatuzumab_tetraxetan wikiPageRevisionID "471104861".
- Yttrium_(90Y)_clivatuzumab_tetraxetan atcPrefix "none".
- Yttrium_(90Y)_clivatuzumab_tetraxetan c "6496".
- Yttrium_(90Y)_clivatuzumab_tetraxetan casNumber "943976".
- Yttrium_(90Y)_clivatuzumab_tetraxetan chemspiderid "NA".
- Yttrium_(90Y)_clivatuzumab_tetraxetan drugName "Yttrium clivatuzumab tetraxetan".
- Yttrium_(90Y)_clivatuzumab_tetraxetan h "9952".
- Yttrium_(90Y)_clivatuzumab_tetraxetan hasPhotoCollection Yttrium_(90Y)_clivatuzumab_tetraxetan.
- Yttrium_(90Y)_clivatuzumab_tetraxetan mabType "mab".
- Yttrium_(90Y)_clivatuzumab_tetraxetan molecularWeight "145.7".
- Yttrium_(90Y)_clivatuzumab_tetraxetan n "1716".
- Yttrium_(90Y)_clivatuzumab_tetraxetan o "2014".
- Yttrium_(90Y)_clivatuzumab_tetraxetan s "44".
- Yttrium_(90Y)_clivatuzumab_tetraxetan source "zu/o".
- Yttrium_(90Y)_clivatuzumab_tetraxetan target MUC1.
- Yttrium_(90Y)_clivatuzumab_tetraxetan type "mab".
- Yttrium_(90Y)_clivatuzumab_tetraxetan verifiedfields "changed".
- Yttrium_(90Y)_clivatuzumab_tetraxetan verifiedrevid "470634923".
- Yttrium_(90Y)_clivatuzumab_tetraxetan subject Category:Monoclonal_antibodies.
- Yttrium_(90Y)_clivatuzumab_tetraxetan type Drug.
- Yttrium_(90Y)_clivatuzumab_tetraxetan type FunctionalSubstance.
- Yttrium_(90Y)_clivatuzumab_tetraxetan comment "Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody designed for the treatment of pancreatic cancer. The antibody itself, clivatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.The drug was developed by Immunomedics, Inc.".
- Yttrium_(90Y)_clivatuzumab_tetraxetan label "Yttrium (90Y) clivatuzumab tetraxetan".
- Yttrium_(90Y)_clivatuzumab_tetraxetan label "إتريوم (90إ) كليفاتوزوماب تتراكسيتان".
- Yttrium_(90Y)_clivatuzumab_tetraxetan sameAs m.0h54cv0.
- Yttrium_(90Y)_clivatuzumab_tetraxetan sameAs Q7381696.
- Yttrium_(90Y)_clivatuzumab_tetraxetan sameAs Q7381696.
- Yttrium_(90Y)_clivatuzumab_tetraxetan wasDerivedFrom Yttrium_(90Y)_clivatuzumab_tetraxetan?oldid=471104861.
- Yttrium_(90Y)_clivatuzumab_tetraxetan isPrimaryTopicOf Yttrium_(90Y)_clivatuzumab_tetraxetan.
- Yttrium_(90Y)_clivatuzumab_tetraxetan name "Yttrium (90Y) clivatuzumab tetraxetan".